Plasmid DNA Manufacturing Global Market Size Like to Reach $5.49 Billion at a CAGR of 23.7% by 2028 | Catalent Inc., Recipharm AB, Kaneka Corp., Aldevron LLC, Celonic AG

"The new report published by The Business Research Company, titled ""Plasmid DNA Manufacturing Global Market Report 2024 - Market Size, Trends, And Global Forecast 2024-2033"", delivers an in-depth analysis of the leading size and forecasts, investment opportunities, winning strategies, market drivers and trends, competitive landscape, and evolving market trends.

As per the report, the plasmid DNA manufacturing market size has grown exponentially in recent years. It will grow from $1.89 billion in 2023 to $2.34 billion in 2024 at a compound annual growth rate (CAGR) of 23.6%. The plasmid DNA manufacturing market size is expected to see exponential growth in the next few years. It will grow to $5.49 billion in 2028 at a compound annual growth rate (CAGR) of 23.7%.

Download Free Sample Report @ https://www.thebusinessresearchcompany.com/sample.aspx?id=15895&type=smp

Gene Therapy Fueling Growth in Plasmid DNA Manufacturing Market
The growing acceptance of gene therapy is expected to propel the growth of the plasmid DNA manufacturing market going forward. Gene therapy refers to a medical treatment that involves modifying or manipulating a person's genes to treat or prevent disease. Gene therapy is on the rise due to advancements in genetic engineering technologies, increased investment in research and development, successful clinical trials, and the growing prevalence of genetic disorders, which together highlight its potential for providing long-term or permanent cures. Plasmid DNA manufacturing is essential for gene therapy as it produces the vectors needed to deliver therapeutic genes into cells, facilitating the treatment of genetic disorders. For instance, according to the American Society of Gene & Cell Therapy, a US-based non-profit medical and scientific organization, the number of gene therapies in Phase III clinical trials grew by 10% in Q3 2023, the first quarterly increase since Q3 2022. Therefore, the growing acceptance of gene therapy is driving the growth of the plasmid DNA manufacturing market.

Innovations In Plasmid DNA Production For Advanced Therapies
Major companies operating in the plasmid DNA manufacturing market are developing advanced bioprocessing technologies to enhance the efficiency, scalability, and quality of plasmid DNA production. These innovations aim to streamline the manufacturing process, reduce production costs, and ensure that the plasmid DNA meets stringent regulatory standards for therapeutic applications. For instance, in January 2023, Charles River Laboratories, a US-based pharmaceutical company, launched eXpDNA platform, designed for the efficient production and purification of high-quality plasmid DNA. This platform integrates advanced bioprocessing technologies, scalable production methods, and rigorous quality control measures to produce plasmid DNA that meets the stringent requirements for therapeutic and clinical applications. The eXpDNA platform is used extensively in gene therapy, DNA vaccine development, and other biopharmaceutical applications that demand high yield, purity, and consistency.

The plasmid DNA manufacturing market covered in this report is segmented -

1) By Grade: Research And Development Grade, Good Manufacturing Practice (GMP) Grade
2) By Development Phase: Pre-Clinical Therapeutics, Clinical Therapeutics, Marketed Therapeutics
3) By Disease: Infectious Disease, Cancer, Genetic Disorder, Other Diseases
4) By Application: Deoxyribonucleic Acid (DNA) Vaccines, Cell And Gene Therapy, Immunotherapy, Other Applications

Buy Now & Get Exclusive Discount on this Report, Checkout link @
https://www.thebusinessresearchcompany.com/Discount?id=15895&type=discount

Major companies operating in the plasmid DNA manufacturing market are Thermo Fisher Scientific Inc., Eurofins Genomics LLC, Catalent Inc., Charles River Laboratories, Recipharm AB, Kaneka Corp., Genscript Biotech Corporation, Aldevron LLC, Genewiz, OriGene Technologies, Celonic AG, Creative Biogene, Cellectis, Synbio Technologies, VectorBuilder Inc., Altogen Biosystems, Addgene, Andelyn Biosciences, AGC Biologics, VGXI, BioCat GmbH, GeneCopoeia, PlasmidFactory GmbH & Co. KG, Akron Biotech, PackGene Biotech lnc.

Contents of the report:
1. Executive Summary
2. Plasmid DNA Manufacturing Market Report Structure
3. Plasmid DNA Manufacturing Market Trends And Strategies
4. Plasmid DNA Manufacturing Market - Macro Economic Scenario
5. Plasmid DNA Manufacturing Market Size And Growth
…..
27. Plasmid DNA Manufacturing Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Explore the report store to make a direct purchase of the report @ https://www.thebusinessresearchcompany.com/report/plasmid-dna-manufacturing-global-market-report

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ "

Learn More About The Business Research Company

The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.

This release was published on openPR.